Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions

Ritu Salani, Ben Davidson, Michael Fiegl, Christian Marth, Elisabeth Müller-Holzner, Guenther Gastl, Han Yao Huang, Jui Chi Hsiao, Her Sheng Lin, Tian Li Wang, Bai Ling Lin, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Purpose: Previous studies have shown that the concentration of cell-free DNA was higher and its strand length longer in body fluids obtained from patients with cancer as compared to patients with benign diseases. We hypothesized that analysis of both DNA copy number and strand length of cell-free DNA from an amplified chromosomal region could improve the diagnosis of malignant diseases in body fluids. Experimental Design: To test this hypothesis, we used ovarian cancer effusion as an example and applied a quantitative real-time PCR tomeasure the relative copy number and strand length of DNA fragments from one of the most frequently amplified genes, cyclin E, in ovarian serous carcinomas. Results: As compared with nonamplified chromosomal loci, including β-actin, p53, 2p24.1, and 4p15.31, measurement of cyclin E DNA copy number (100 bp) had the best performance in distinguishing malignant (n = 88) frombenign (n = 70) effusions after normalization to effusion volume or Line-1 DNA with areas under the receiver operating characteristics curve (AUC) of 0.832 and 0.847, respectively. Different DNA lengths of the cyclin E locus were further analyzed and we found that the AUC was highest by measuring the 400-bp cyclin E locus (AUC = 0.896). The AUC was improved to 0.936 when it was combined with the length integrity index as defined by the relative abundance of 400 bp cyclin E to 100 bp p53 loci. Cyclin E real-time PCR assay had a higher sensitivity (95.6%) than routine cytology examination (73.9%) and was able to diagnose false-negative cytology cases in this study. Conclusions: The above findings indicate that measurement of the DNA copy number and strand length of the cyclin E locus is a useful cancer diagnostic tool.

Original languageEnglish (US)
Pages (from-to)5805-5809
Number of pages5
JournalClinical Cancer Research
Volume13
Issue number19
DOIs
StatePublished - Oct 1 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions'. Together they form a unique fingerprint.

  • Cite this

    Salani, R., Davidson, B., Fiegl, M., Marth, C., Müller-Holzner, E., Gastl, G., Huang, H. Y., Hsiao, J. C., Lin, H. S., Wang, T. L., Lin, B. L., & Shih, I. M. (2007). Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions. Clinical Cancer Research, 13(19), 5805-5809. https://doi.org/10.1158/1078-0432.CCR-07-0853